Repetitive transcranial magnetic stimulation as an adjunctive treatment for negative symptoms and cognitive impairment in patients with schizophrenia: a randomized, double-blind, sham-controlled trial
Kaiming Zhuo,1 Yingying Tang,1,2 Zhenhua Song,1 Yingchan Wang,1 Junjie Wang,2 Zhenying Qian,2 Hui Li,2 Qiong Xiang,1 Tianyi Chen,1,3 Zhilei Yang,1,4 Yifeng Xu,1,5 Xiaoduo Fan,6 Jijun Wang,1–2,5 Dengtang Liu1,51First-episode Schizophrenia and Early Psychosis Program, Division of Psychotic D...
Guardado en:
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/58b7156d75fb4157b96be585f1a77028 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:58b7156d75fb4157b96be585f1a77028 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:58b7156d75fb4157b96be585f1a770282021-12-02T03:15:53ZRepetitive transcranial magnetic stimulation as an adjunctive treatment for negative symptoms and cognitive impairment in patients with schizophrenia: a randomized, double-blind, sham-controlled trial1178-2021https://doaj.org/article/58b7156d75fb4157b96be585f1a770282019-05-01T00:00:00Zhttps://www.dovepress.com/repetitive-transcranial-magnetic-stimulation-as-an-adjunctive-treatmen-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Kaiming Zhuo,1 Yingying Tang,1,2 Zhenhua Song,1 Yingchan Wang,1 Junjie Wang,2 Zhenying Qian,2 Hui Li,2 Qiong Xiang,1 Tianyi Chen,1,3 Zhilei Yang,1,4 Yifeng Xu,1,5 Xiaoduo Fan,6 Jijun Wang,1–2,5 Dengtang Liu1,51First-episode Schizophrenia and Early Psychosis Program, Division of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China; 2Department of EEG and Imaging, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China; 3Shanghai Hong Kou Mental Health Center, Shanghai, People’s Republic of China; 4Shanghai Jia Ding Mental Health Center, Division of Psychotic Disorders, Shanghai, People’s Republic of China; 5Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China; 6Psychotic Disorders Program, UMass Memorial Medical Center, University of Massachusetts Medical School, Worcester, MA, USAPurpose: Effective treatment options for negative symptoms and cognitive impairment in patients with schizophrenia are still to be developed. The present study was to examine potential benefits of repetitive transcranial magnetic stimulation (rTMS) to improve negative symptoms and cognition in this patient population.Methods: The study was a 4-week, randomized, double-blind sham-controlled trial. Patients with schizophrenia were treated with adjunctive 20-Hz rTMS for 4 weeks or sham condition to the left dorsolateral prefrontal cortex (DLPFC). Negative symptoms were measured using the Scale for the Assessment of Negative Symptoms (SANS) and the Positive and Negative symptom scale (PANSS) negative subscale at baseline and week 4. Cognitive function was measured using the MATRICS Consensus Cognitive Battery (MCCB) at the same two time points. In addition, possible moderators for rTMS treatment efficacy were explored.Results: Sixty patients (33 in the treatment group, 27 in the sham group) completed the study. There was a significant decrease in negative symptoms after 4-week rTMS treatment as measured by the SANS total score and the PANSS negative symptom subscale score. However, there was no significant improvement in cognition with rTMS treatment. Stepwise multiple linear regression analysis suggested that the baseline severity of positive symptoms may predict poorer improvement in negative symptoms at week 4.Conclusion: Twenty-Hz rTMS stimulation over left DLPFC as an adjunctive treatment might be beneficial in improving negative symptoms of schizophrenia. Future studies with a longer treatment duration and a larger sample size are needed.Clinical trial ID: NCT01940939.Keywords: schizophrenia, negative symptoms, cognitive impairment, repetitive transcranial magnetic stimulation, rTMS, MCCBZhuo KTang YSong ZWang YWang JQian ZLi HXiang QChen TYang ZXu YFan XWang JLiu DDove Medical PressarticleSchizophreniaNegative symptomsCognitive impairmentRepetitive transcranial magnetic stimulation (rTMS)MCCBNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 15, Pp 1141-1150 (2019) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Schizophrenia Negative symptoms Cognitive impairment Repetitive transcranial magnetic stimulation (rTMS) MCCB Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 |
spellingShingle |
Schizophrenia Negative symptoms Cognitive impairment Repetitive transcranial magnetic stimulation (rTMS) MCCB Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Zhuo K Tang Y Song Z Wang Y Wang J Qian Z Li H Xiang Q Chen T Yang Z Xu Y Fan X Wang J Liu D Repetitive transcranial magnetic stimulation as an adjunctive treatment for negative symptoms and cognitive impairment in patients with schizophrenia: a randomized, double-blind, sham-controlled trial |
description |
Kaiming Zhuo,1 Yingying Tang,1,2 Zhenhua Song,1 Yingchan Wang,1 Junjie Wang,2 Zhenying Qian,2 Hui Li,2 Qiong Xiang,1 Tianyi Chen,1,3 Zhilei Yang,1,4 Yifeng Xu,1,5 Xiaoduo Fan,6 Jijun Wang,1–2,5 Dengtang Liu1,51First-episode Schizophrenia and Early Psychosis Program, Division of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China; 2Department of EEG and Imaging, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China; 3Shanghai Hong Kou Mental Health Center, Shanghai, People’s Republic of China; 4Shanghai Jia Ding Mental Health Center, Division of Psychotic Disorders, Shanghai, People’s Republic of China; 5Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China; 6Psychotic Disorders Program, UMass Memorial Medical Center, University of Massachusetts Medical School, Worcester, MA, USAPurpose: Effective treatment options for negative symptoms and cognitive impairment in patients with schizophrenia are still to be developed. The present study was to examine potential benefits of repetitive transcranial magnetic stimulation (rTMS) to improve negative symptoms and cognition in this patient population.Methods: The study was a 4-week, randomized, double-blind sham-controlled trial. Patients with schizophrenia were treated with adjunctive 20-Hz rTMS for 4 weeks or sham condition to the left dorsolateral prefrontal cortex (DLPFC). Negative symptoms were measured using the Scale for the Assessment of Negative Symptoms (SANS) and the Positive and Negative symptom scale (PANSS) negative subscale at baseline and week 4. Cognitive function was measured using the MATRICS Consensus Cognitive Battery (MCCB) at the same two time points. In addition, possible moderators for rTMS treatment efficacy were explored.Results: Sixty patients (33 in the treatment group, 27 in the sham group) completed the study. There was a significant decrease in negative symptoms after 4-week rTMS treatment as measured by the SANS total score and the PANSS negative symptom subscale score. However, there was no significant improvement in cognition with rTMS treatment. Stepwise multiple linear regression analysis suggested that the baseline severity of positive symptoms may predict poorer improvement in negative symptoms at week 4.Conclusion: Twenty-Hz rTMS stimulation over left DLPFC as an adjunctive treatment might be beneficial in improving negative symptoms of schizophrenia. Future studies with a longer treatment duration and a larger sample size are needed.Clinical trial ID: NCT01940939.Keywords: schizophrenia, negative symptoms, cognitive impairment, repetitive transcranial magnetic stimulation, rTMS, MCCB |
format |
article |
author |
Zhuo K Tang Y Song Z Wang Y Wang J Qian Z Li H Xiang Q Chen T Yang Z Xu Y Fan X Wang J Liu D |
author_facet |
Zhuo K Tang Y Song Z Wang Y Wang J Qian Z Li H Xiang Q Chen T Yang Z Xu Y Fan X Wang J Liu D |
author_sort |
Zhuo K |
title |
Repetitive transcranial magnetic stimulation as an adjunctive treatment for negative symptoms and cognitive impairment in patients with schizophrenia: a randomized, double-blind, sham-controlled trial |
title_short |
Repetitive transcranial magnetic stimulation as an adjunctive treatment for negative symptoms and cognitive impairment in patients with schizophrenia: a randomized, double-blind, sham-controlled trial |
title_full |
Repetitive transcranial magnetic stimulation as an adjunctive treatment for negative symptoms and cognitive impairment in patients with schizophrenia: a randomized, double-blind, sham-controlled trial |
title_fullStr |
Repetitive transcranial magnetic stimulation as an adjunctive treatment for negative symptoms and cognitive impairment in patients with schizophrenia: a randomized, double-blind, sham-controlled trial |
title_full_unstemmed |
Repetitive transcranial magnetic stimulation as an adjunctive treatment for negative symptoms and cognitive impairment in patients with schizophrenia: a randomized, double-blind, sham-controlled trial |
title_sort |
repetitive transcranial magnetic stimulation as an adjunctive treatment for negative symptoms and cognitive impairment in patients with schizophrenia: a randomized, double-blind, sham-controlled trial |
publisher |
Dove Medical Press |
publishDate |
2019 |
url |
https://doaj.org/article/58b7156d75fb4157b96be585f1a77028 |
work_keys_str_mv |
AT zhuok repetitivetranscranialmagneticstimulationasanadjunctivetreatmentfornegativesymptomsandcognitiveimpairmentinpatientswithschizophreniaarandomizeddoubleblindshamcontrolledtrial AT tangy repetitivetranscranialmagneticstimulationasanadjunctivetreatmentfornegativesymptomsandcognitiveimpairmentinpatientswithschizophreniaarandomizeddoubleblindshamcontrolledtrial AT songz repetitivetranscranialmagneticstimulationasanadjunctivetreatmentfornegativesymptomsandcognitiveimpairmentinpatientswithschizophreniaarandomizeddoubleblindshamcontrolledtrial AT wangy repetitivetranscranialmagneticstimulationasanadjunctivetreatmentfornegativesymptomsandcognitiveimpairmentinpatientswithschizophreniaarandomizeddoubleblindshamcontrolledtrial AT wangj repetitivetranscranialmagneticstimulationasanadjunctivetreatmentfornegativesymptomsandcognitiveimpairmentinpatientswithschizophreniaarandomizeddoubleblindshamcontrolledtrial AT qianz repetitivetranscranialmagneticstimulationasanadjunctivetreatmentfornegativesymptomsandcognitiveimpairmentinpatientswithschizophreniaarandomizeddoubleblindshamcontrolledtrial AT lih repetitivetranscranialmagneticstimulationasanadjunctivetreatmentfornegativesymptomsandcognitiveimpairmentinpatientswithschizophreniaarandomizeddoubleblindshamcontrolledtrial AT xiangq repetitivetranscranialmagneticstimulationasanadjunctivetreatmentfornegativesymptomsandcognitiveimpairmentinpatientswithschizophreniaarandomizeddoubleblindshamcontrolledtrial AT chent repetitivetranscranialmagneticstimulationasanadjunctivetreatmentfornegativesymptomsandcognitiveimpairmentinpatientswithschizophreniaarandomizeddoubleblindshamcontrolledtrial AT yangz repetitivetranscranialmagneticstimulationasanadjunctivetreatmentfornegativesymptomsandcognitiveimpairmentinpatientswithschizophreniaarandomizeddoubleblindshamcontrolledtrial AT xuy repetitivetranscranialmagneticstimulationasanadjunctivetreatmentfornegativesymptomsandcognitiveimpairmentinpatientswithschizophreniaarandomizeddoubleblindshamcontrolledtrial AT fanx repetitivetranscranialmagneticstimulationasanadjunctivetreatmentfornegativesymptomsandcognitiveimpairmentinpatientswithschizophreniaarandomizeddoubleblindshamcontrolledtrial AT wangj repetitivetranscranialmagneticstimulationasanadjunctivetreatmentfornegativesymptomsandcognitiveimpairmentinpatientswithschizophreniaarandomizeddoubleblindshamcontrolledtrial AT liud repetitivetranscranialmagneticstimulationasanadjunctivetreatmentfornegativesymptomsandcognitiveimpairmentinpatientswithschizophreniaarandomizeddoubleblindshamcontrolledtrial |
_version_ |
1718401855042617344 |